Retinal venous occlusion following COVID-19 vaccination: Report of a case after third dose and review of the literature |
| |
Authors: | Parthopratim Dutta Majumder Vadivelu Jaya Prakash |
| |
Affiliation: | Medical and Vision Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India;1.Department of Vitreoretina, Medical and Vision Research Foundations, Sankara Nethralaya, Sankara Nethralaya, Chennai, Tamil Nadu, India |
| |
Abstract: | A 28-year-old, healthy male presented with blurring of vision in the right eye following third dose of the AstraZeneca/COVISHIELD vaccine. Further examination revealed ischemic central retinal vein occlusion, and subsequent laboratory investigations were inconclusive for his eye disease. He responded to pulse corticosteroid and tapering doses of oral corticosteroids without requiring any intra-vitreal injection. Twelve articles were identified with the help of a PubMed literature search, and a short review of these patients was performed. Retinal vein occlusion can occur because of inflammation-induced thrombosis after coronavirus disease 2019 vaccination and may respond to anti-inflammatory therapy. |
| |
Keywords: | Anti-inflammatory therapy COVID-19 COVID-19 vaccine retinal vein occlusion |
|
|